Know Cancer

or
forgot password

Pilot Study of STAR, an Internet-based System for Cancer Patients to Self-report Toxicity Symptoms, Performance Status, and Quality of Life


N/A
18 Years
N/A
Open (Enrolling)
Both
Cervical Cancer, Lung Cancer, Prostate Cancer, Vaginal Cancer, Ovarian Cancer, Breast Cancer, Bladder Cancer

Thank you

Trial Information

Pilot Study of STAR, an Internet-based System for Cancer Patients to Self-report Toxicity Symptoms, Performance Status, and Quality of Life


This pilot study will assess patient use of STAR (Symptom Tracking and Reporting for
Patients), an online system designed for cancer patients to self-record toxicity-related
symptoms based on NCI Common Terminology Criteria for Adverse Events v3.0, performance
status by ECOG criteria, and global quality of life by the EuroQOL 5-D assessment tool.
Secondary outcomes will include patient assessment of the usefulness of STAR, clinician
perceptions of the potential value of STAR in routine clinical practice, and an evaluation
of whether STAR improves the patient experience of care as assessed by quality of life and
satisfaction measures.


Inclusion Criteria:



- Age >18 years

- Diagnosis of gynecologic (ovarian; cervical; uterine; primary peritoneal), lung
(non-small cell; small cell), gastrointestinal (colorectal, rectal, gastric,
esophageal, GI neuroendocrine, small intestine malignancy, pancreatic,
hepatocellular), breast, bladder cancer or prostate malignancy

- Receiving primary medical oncology care at MSKCC medical oncology outpatient clinics

- Receiving cytotoxic chemotherapy not on a clinical trial (or a new hormonal therapy
in the case of prostate cancer patients only), with treatment expected to continue
for at least four weeks from the time of enrollment

- Signed informed consent and Research Authorization

Exclusion Criteria:

- ECOG performance status greater than 2

- Unable to read and comprehend English language text

Type of Study:

Observational

Study Design:

Time Perspective: Prospective

Outcome Measure:

To evaluate patient willingness to use STAR (Symptom Tracking and Reporting for Patients), an Internet-based system for cancer patients to self-report common toxicity symptoms, performance status, and quality of life.

Outcome Time Frame:

conclusion of study

Safety Issue:

No

Principal Investigator

Ethan Basch, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

04-020

NCT ID:

NCT00578006

Start Date:

March 2004

Completion Date:

December 2013

Related Keywords:

  • Cervical Cancer
  • Lung Cancer
  • Prostate Cancer
  • Vaginal Cancer
  • Ovarian Cancer
  • Breast Cancer
  • Bladder Cancer
  • toxicity related symptoms
  • 04-020
  • Urinary Bladder Neoplasms
  • Breast Neoplasms
  • Uterine Cervical Neoplasms
  • Lung Neoplasms
  • Ovarian Neoplasms
  • Prostatic Neoplasms
  • Vaginal Neoplasms

Name

Location
Memorial Sloan-Kettering Cancer Center New York, New York  10021